DNA methylation is a general mechanism of controlling tissue-specific gene expression. Osteocalcin is a bone matrix protein whose expression is limited almost entirely to osteoblasts. We were interested in determining whether the state of methylation of the osteocalcin gene plays a role in its expre
Requirement of distal and proximal promoter sequences for chromatin organization of the osteocalcin gene in bone-derived cells
✍ Scribed by Martin Montecino; Baruch Frenkel; Jane Lian; Janet Stein; Gary Stein
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 744 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
The osteocalcin (OC) gene encodes a 10 Kda bone-specific protein which is expressed with the onset of mineralization during the differentiation of normal diploid osteoblasts. We have previously reported that transcriptional activation of this gene is accompanied by the presence of two DNase I hypersensitive sites, both located in the promoter region spanning key basal (proximal site, -1 70 to -70) and steroid-dependent enhancer (distal site, -600 to -400) elements. Here, we have examined stably transfected ROS 1 7/2.8 cell lines carrying OC promoter-reporter transgenes which contain a series of 5'-deletions and determined the effects of these truncations on the chromatin organization. It has been found that: (1) DNase I hypersensitivity at -600 is not a requirement for vitamin D-dependent transcriptional upregulation; (2) basal transcriptional activity and proximal nuclease hypersensitivity depend exclusively on protein-DNA interactions occurring within the proximal promoter region, and ( 3 ) within the chromatin context, the proximal 100 bp promoter fragment, containing essential elements such as the OC box (-99 to -76) and TATA box (-44 to -31 ), is insufficient to support formation of the proximal nuclease hypersensitive site and transcriptional activity.
📜 SIMILAR VOLUMES
## Abstract Syndecan‐1 (CD138) is a cell membrane proteoglycan that binds extracellular matrix components and various growth factors. The role of syndecan‐1 in the control of cell growth and morphology has been illustrated by its altered expression in hematological malignancies such as multiple mye
Our previous studies have shown that transcription of brain creatine kinase (CKB) mRNA in U87-MG glioblastoma cells is stimulated by a forskolinmediated increase in cyclic AMP (cAMP) via a pathway involving protein kinase A (PKA) and the activation of G␣ s proteins. In this report, we have employed